HIMS & LLY insiders transactionsBoth companies are facing legal issues, but the respond to stock price from the management of each company are different.
Disclaimer: This content is NOT a financial advise, it is for educational purpose only.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
16.51 MXN
2.63 B MXN
30.78 B MXN
202.65 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG01PDTP365
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
Hims & Hers Health (HIMS) AnalysisHims & Hers Health NYSE:HIMS is a leading telehealth platform delivering personalized care in sexual health, hair loss, dermatology, mental health, and weight loss.
Growth Drivers:
Weight Loss Service Momentum ⚡
Q1 2025 launch of a GLP-1 prescription program with coaching & diagnostics has unlo
Hims taking some off here I hope i'm wrong, but i took off about 50% of my position. I'm bearish short term, healthcare stocks just getting wrecked left and right. I'd add back in the green horizontals if tested in the 36-32 range. The Hims position has run up a little too much in size than I'm comfortable with, happy to tak
HIMS LONG Swing Entry PlanNYSE:HIMS LONG Swing Entry Plan
Entry Zone 1: $46.10 – $46.50
→ Open initial position targeting +8% from entry level.
Entry Zone 2: $43.00 – $43.20
→ If price dips further, average down with a second equal-sized entry.
→ New target becomes +8% from the average of Entry 1 and Entry 2.
AD Zone
Hims buy zoneHims is back into the buy zone which I have updated. The last buy zone barely gave an entry on a single weekly candle wick. Note the rising average weekly volume. Volatility is cooling alongside momentum. We saw another rejection of weekly supply which means that is a true selling zone. We just hit
HIMS Bearish Breakdown — Weekly Put Option Setup🚨 HIMS Bearish Breakdown — Weekly Put Option Setup**
Hims & Hers (HIMS) shows strong institutional selling pressure with a clear breakdown below key support levels. Multiple models (Google Gemini, DeepSeek, Claude) confirm bearish momentum fueled by heavy volume, insider selling, and ongoing legal
I am bullish on HIMSI am bullish on HIMS
My mid to long-term view for Hims & Hers is bullish and shown on my chart
My entry and traget is displayed technically
[$HIMS] Beautiful wellness trade - Plan changed overnightNYSE:HIMS
The plan was too SHORT (BEAR CALL SPREADs) NYSE:HIMS @66.0 USD.
Outside regular trading hours it dumped and spiked back from 55.0 USD up to 62.0 USD.
-> technical pattern 3 White Soldiers
Short Story Long: I went long at 55.0 USD (Cash Secured Puts) seeing a strong support at this
Grok Bets Big on HIMS $60 Calls
**HIMS \$60C in Play! Mixed Models, But Grok Goes Bullish 💥 \ **
---
### 🧠 TradingView-Ready Caption:
**HIMS Weekly Trade Alert 🚨 | Aug 8 Expiry**
> While most models stay cautious, **Grok/xAI pulls the trigger** on a bullish call. Weekly RSI rising, volume weak but stable. Entry at market open
Hims new momentum zoneHims hit my new momentum zone perfectly on the dump. I had this drawn after the initial down leg, hoping the daily gap would fill to the downside. We see a nice hard stop at the buy zone, the stock could easily slide down to 47, but we are seeing strong action from buyers here. Now if only NVO would
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 826.08 MXN — it has increased by 0.43% in the past 24 hours. Watch HIMS & HERS HEALTH, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange HIMS & HERS HEALTH, INC stocks are traded under the ticker HIMS.
HIMS stock has fallen by −6.84% compared to the previous week, the month change is a −11.29% fall, over the last year HIMS & HERS HEALTH, INC has showed a 158.38% increase.
We've gathered analysts' opinions on HIMS & HERS HEALTH, INC future price: according to them, HIMS price has a max estimate of 1,594.45 MXN and a min estimate of 525.23 MXN. Watch HIMS chart and read a more detailed HIMS & HERS HEALTH, INC stock forecast: see what analysts think of HIMS & HERS HEALTH, INC and suggest that you do with its stocks.
HIMS stock is 6.18% volatile and has beta coefficient of 2.64. Track HIMS & HERS HEALTH, INC stock price on the chart and check out the list of the most volatile stocks — is HIMS & HERS HEALTH, INC there?
Today HIMS & HERS HEALTH, INC has the market capitalization of 188.96 B, it has decreased by −5.15% over the last week.
Yes, you can track HIMS & HERS HEALTH, INC financials in yearly and quarterly reports right on TradingView.
HIMS & HERS HEALTH, INC is going to release the next earnings report on Nov 10, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 3.19 MXN per share, whereas the estimation was 2.83 MXN resulting in a 12.73% surprise. The estimated earnings for the next quarter are 1.79 MXN per share. See more details about HIMS & HERS HEALTH, INC earnings.
HIMS & HERS HEALTH, INC revenue for the last quarter amounts to 10.22 B MXN, despite the estimated figure of 10.35 B MXN. In the next quarter, revenue is expected to reach 10.87 B MXN.
HIMS net income for the last quarter is 797.32 M MXN, while the quarter before that showed 1.01 B MXN of net income which accounts for −21.35% change. Track more HIMS & HERS HEALTH, INC financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 24, 2025, the company has 1.64 K employees. See our rating of the largest employees — is HIMS & HERS HEALTH, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIMS & HERS HEALTH, INC EBITDA is 3.11 B MXN, and current EBITDA margin is 5.76%. See more stats in HIMS & HERS HEALTH, INC financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIMS & HERS HEALTH, INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIMS & HERS HEALTH, INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIMS & HERS HEALTH, INC stock shows the neutral signal. See more of HIMS & HERS HEALTH, INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.